Gene Biotherapeutics (Gene Biotherapeutics) EBITDA Margin % : 0.00% (As of Dec. 2020)

Gene Biotherapeutics EBITDA Margin % Chart

Gene Biotherapeutics Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EBITDA Margin %		Get a 7-Day Free Trial					-	-	-	-	-

Gene Biotherapeutics Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gene Biotherapeutics's EBITDA Margin %

For the Biotechnology subindustry, Gene Biotherapeutics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gene Biotherapeutics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gene Biotherapeutics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Gene Biotherapeutics's EBITDA Margin % falls into.

Gene Biotherapeutics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Gene Biotherapeutics's EBITDA Margin % for the fiscal year that ended in Dec. 2020 is calculated as

Gene Biotherapeutics's EBITDA Margin % for the quarter that ended in Dec. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gene Biotherapeutics  (OTCPK:CRXM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Gene Biotherapeutics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Gene Biotherapeutics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gene Biotherapeutics (Gene Biotherapeutics) Business Description